Connect your AI

NetSTREIT NTST Deferred offering costs

Deferred offering costs at other companies

Nurix Therapeutics, Inc.NRIX

$100K0.0%

Mineralys Therapeutics, Inc.MLYS

$200K-33.3%

Sonida Senior LivingSNDA

$0—

Chicago Atlantic Real Estate FinanceREFI

$100M—

Schering-PloughSGP

$17K—

NetSTREITNTST

$259K-20.0%

Other financials

Income statement

Revenue$57.1M+24.3%

Net income$5.7M+236%

EPS (diluted)$0.06+200%

Balance sheet

Cash & equivalents$11.1M-22.2%

Total debt$1.2B+34.9%

Total equity$1.5B+15.2%

Total assets$2.8B+23.0%

Cash flow

Operating cash flow$26.3M+19.1%

CapEx--100%

Free cash flow$26.3M+19.2%

Valuation

Market cap$1.94B+59.5%

Enterprise value$3.16B+49.8%

P/E177.2×—

P/S9.4×+2.3×

Profitability

Net margin5.3%+3.4pp

FCF margin55.1%-3.7pp

Returns & leverage

Return on equity0.8%+0.5pp

Debt / equity0.8×+0.1×

Where this comes from

Reported directly by NetSTREIT in its filing.

Tagged under the XBRL concept us-gaap:DeferredOfferingCosts.

The official record: NetSTREIT’s 10-Q, filed April 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about NetSTREIT's deferred offering costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is NetSTREIT's deferred offering costs?: NetSTREIT (NTST) reported deferred offering costs of $2.72M in Q1 2026.
How has NetSTREIT's deferred offering costs changed year-over-year?: NetSTREIT's deferred offering costs increased by 58.0% year-over-year, from $1.72M to $2.72M.